Loading...

Bayer

 

NTRK gene fusion testing – Creating an integrated team approach for tissue agnostic biomarkers

Date: Sunday, June 23
Time: 0730-0830
Room: Strategy 2, Sheraton on the Falls Hotel

Last Name
First Name
Organization
Email
Yes!

Join us for breakfast on Sunday June 23 at CAP-ACP 2019!

You are cordially invited to attend a Bayer Satellite Symposium

 

NTRK gene fusion testing – Creating an integrated team approach for tissue agnostic biomarkers

 

Learning Objectives:

  • Learn how precision medicine is playing a role in tumor agnostic biomarker detection.
  • Understand the biology of TRK fusion cancer and NTRK gene fusions.
  • Assess testing strategies for identifying NTRK gene fusions.
  • Discuss the Canadian testing landscape and algorithms for NTRK gene fusion testing in various tumour types.

 

Time:
0730-0830, Breakfast will be served starting at 0700

Room:
Strategy 2, Sheraton on the Falls Hotel

 

MODERATOR:

Diana Ionescu 

Diana Ionescu, MD, FRCP(C), FCAP

Consultant Pathologist

Medical Director Clinical Trials, BCCA Laboratories

Clinical Professor, University of British Columbia

 

 

SPEAKERS:

Shantanu Banerji 

Shantanu Banerji, MD, FRCPC

Director, Precision Medicine and Advanced Therapeutics

CancerCare Manitoba

Assistant Professor, Department of Internal Medicine

Rady Faculty of Health Sciences, University of Manitoba

 

 

Harriet Feilotter 

Harriet Feilotter, PhD, FCCMG, FACMG

Professor, Department of Pathology and Molecular Medicine

Queen’s University

Director, Molecular Diagnostics

Kingston Health Sciences Centre

 

 

Ming Tsao 

Ming Tsao, MD, FRCPC

Consultant Pathologist

University Health Network, Princess Margaret Cancer Centre

Professor, Department of Laboratory Medicine and Pathobiology

University of Toronto